AKT1 and cancer: According to in silico molecular docking studies and in vitro si-RNA studies, trans-(−)-kusunokinin targeted CSF1R, inhibiting the receptor and AKT signalling cascade, and thus suppressing cancer cell proliferation and metastasis53,54.